Sword Diagnostics: Accelerating Drug Development through dramatically enhanced sensitivity and reproducibility, without the need for special instrumentation, or complex processes
iCrowdNewswire -
Aug 17, 2016 2:23 PM ET
Sword Diagnostics
Accelerating Drug Development through dramatically enhanced sensitivity and reproducibility, without the need for special instrumentation, or complex processes.
Company Summary
Sword gives pharmaceutical companies the very thing they value most, a faster time to market. Sword enhances their 50 year old testing technology with higher sensitivity and precision, allowing scientists to make better decisions faster, accelerating drug development. Sword’s customers include Bristol-Myers Squibb, Eli Lilly, and Novartis, and the company is currently working with seven of the top 20 pharmaceutical companies in the world.